We are live on
!
Find out more
SR
Syntax Research Portfolio holdings
AUM
$157M
1-Year Est. Return
16.51%
This Fund
S&P 500
This Quarter
Est. Return
-4.88%
1 Year Est. Return
+16.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$123M
AUM Growth
–
Cap. Flow
+$130M
Cap. Flow
% of AUM
105.17%
Top 10 Holdings %
Top 10 Hldgs %
53.1%
Holding
178
New
178
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$11.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.3M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$7.37M |
| 4 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$7.24M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 11.6% |
| 2 | Real Estate | 8.25% |
| 3 | Industrials | 6.4% |
| 4 | Materials | 4.12% |
| 5 | Financials | 2.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Verizon
VZ
$183B
| $75.3K | 0.06% |
+2,323
| New | +$78.5K |
|
77
Pfizer
PFE
$143B
| $75.2K | 0.06% |
+2,267
| New | +$80.2K |
|
78
AT&T
T
$153B
| $69.9K | 0.06% |
+4,653
| New | +$68.2K |
|
79
Netflix
NFLX
$313B
| $66.1K | 0.05% |
+1,750
| New | +$74.2K |
|
80
CVS Health
CVS
$136B
| $65.6K | 0.05% |
+939
| New | +$66.5K |
|
81
Johnson & Johnson
JNJ
$602B
| $64K | 0.05% |
+411
| New | +$67.8K |
|
82
Amgen
AMGN
$201B
| $63.7K | 0.05% |
+237
| New | +$59.1K |
|
83
State Street Financial Select Sector SPDR ETF
XLF
$54.8B
| $57.6K | 0.05% |
+1,737
| New | +$59.9K |
|
84
Lowe's Companies
LOW
$121B
| $57.6K | 0.05% |
+277
| New | +$62.3K |
|
85
PPG Industries
PPG
$26.5B
| $56.7K | 0.05% |
+437
| New | +$61.3K |
|
86
General Dynamics
GD
$99.7B
| $55.7K | 0.05% |
+252
| New | +$55.7K |
|
87
Dollar Tree
DLTR
$24.7B
| $53.2K | 0.04% |
+500
| New | +$67K |
|
88
Globus Medical
GMED
$11B
| $49.6K | 0.04% |
+1,000
| New | +$55.9K |
|
89
iShares Dow Jones US ETF
IYY
$2.94B
| $49.3K | 0.04% |
+472
| New | +$51.3K |
|
90
HP
HPQ
$22.1B
| $48.8K | 0.04% |
+1,897
| New | +$58.2K |
|
91
Thermo Fisher Scientific
TMO
$202B
| $48.6K | 0.04% |
+96
| New | +$51.2K |
|
92
Darden Restaurants
DRI
$23B
| $48.3K | 0.04% |
+337
| New | +$53.4K |
|
93
Eaton
ETN
$154B
| $48K | 0.04% |
+225
| New | +$48.5K |
|
94
NextEra Energy
NEE
$186B
| $47.9K | 0.04% |
+836
| New | +$57.9K |
|
95
SAP
SAP
$189B
| $47.8K | 0.04% |
+370
| New | +$50.4K |
|
96
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $44K | 0.04% |
+1,458
| New | +$44.6K |
|
97
Intercontinental Exchange
ICE
$80.2B
| $42.4K | 0.03% |
+385
| New | +$44.1K |
|
98
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.78B
| $42.2K | 0.03% |
+622
| New | +$43.4K |
|
99
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
| $39.4K | 0.03% |
+961
| New | +$39.7K |
|
100
Walt Disney
DIS
$173B
| $39.4K | 0.03% |
+486
| New | +$41.5K |
|
Similar funds
BRWM
SF
AC
HEM
EP
CF
TPBG
CFG
Syntax Research's Q3 2023 Portfolio in Review
Q3 2023 is the first quarter with a 13F filing on record for Syntax Research, which disclosed 178 positions worth $123M. Its ten largest holdings account for 53% of the portfolio.
Its largest position is iShares Core S&P 500 ETF: 26,623 shares worth $11.4M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, followed by Real Estate and Industrials.
- Syntax Research's largest Q3 2023 buy was iShares Core S&P 500 ETF: 26,623 shares worth $11.4M.
- Syntax Research's ten largest holdings make up 53% of its $123M portfolio in Q3 2023.
- Syntax Research disclosed 178 positions in Q3 2023, its first 13F filing on record.
Based on Syntax Research's 13F filing for Q3 2023, filed 14 Nov 2023.